SMITHKLINE BEECHAM PAXIL U.S. SALES REACH $135 MIL. IN FIRST 10 MONTHS ON MARKET; COMPANY's 1993 U.S. PHARMACEUTICAL SALES INCREASE 11% TO $2.42 BIL.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".